Neurocrine Biosciences
NBIX
#1542
Rank
C$15.87 B
Marketcap
$159.19
Share price
1.61%
Change (1 day)
-16.63%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of December 2024 : C$1.54 Billion

According to Neurocrine Biosciences 's latest financial reports the company has C$1.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.54 B12.86%
2023-12-31C$1.36 B1.92%
2022-12-31C$1.34 B48.09%
2021-12-31C$0.90 B-11.24%
2020-12-31C$1.02 B16.63%
2019-12-31C$0.87 B-1.24%
2018-12-31C$0.88 B36.69%
2017-12-31C$0.64 B57.05%
2016-12-31C$0.41 B-21.48%
2015-12-31C$0.52 B133.88%
2014-12-31C$0.22 B44.97%
2013-12-31C$0.15 B-9.83%
2012-12-31C$0.17 B31.01%
2011-12-31C$0.13 B3.56%
2010-12-31C$0.12 B125.43%
2009-12-31C$56.25 M-42.51%
2008-12-31C$97.84 M-45.32%
2007-12-31C$0.17 B-15.83%
2006-12-31C$0.21 B-33.13%
2005-12-31C$0.31 B-12.1%
2004-12-31C$0.36 B-38.47%
2003-12-31C$0.58 B52.1%
2002-12-31C$0.38 B-24.18%
2001-12-31C$0.50 B106.62%
2000-12-31C$0.24 B87.76%
1999-12-31C$0.13 B630.42%
1998-12-31C$17.98 M-20.32%
1997-12-31C$22.57 M45.86%
1996-12-31C$15.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.12 B-27.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.54 B 64.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$4.91 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.92 B 218.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.98 B 416.22%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.43 B 1,802.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.21 B-85.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.46 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA